9-MTH group results (IFRS)
Feb 5 (Reuters)-
Mitsubishi Chemical Group Corporation
CONSOLIDATED FINANCIAL HIGHLIGHTS
(in billions of yen unless specified)
9 months ended 9 months ended Year to
Dec 31, 2025 Dec 31, 2024 Mar 31, 2026
LATEST YEAR-AGO COMPANY
RESULTS RESULT FORECAST
Sales 2.74 trln 2.98 trln 3.67 trln
(-8.2 pct) (-8.1 pct) (-7.0 pct)
Operating 113.32 145.66 70.00
(-22.2 pct) (-31.5 pct) (-50.5 pct)
Pretax
Net 105.43 59.37 47.00
(+77.6 pct) (-42.8 pct) (+4.4 pct)
EPS Basic 76.70 yen 41.72 yen 34.29 yen
EPS Diluted 76.67 yen 41.70 yen
Ann Div 32.00 yen 32.00 yen
-Q2 Div 16.00 yen 16.00 yen
-Q4 Div 16.00 yen 16.00 yen
NOTE - Mitsubishi Chemical Group Corporation.
(Figures are reported based on international accounting rules (IFRS).)
If there is no Q1 or Q3 dividend, Q2 will in most cases correspond to the first-half
dividend and Q4 to the second-half dividend announced before a new corporate law in
2006 allowed companies to pay and report dividends on a quarterly basis.
*Net - represents Net profit attributable to owners of the parent company.
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4188.T
Recent news on Mitsubishi Chemical
See all newsJapan state-backed fund considering sale of chipmaking materials maker JSR, sources say
Japan state-backed fund considering sale of chipmaking materials maker JSR, sources say
Brief: Mitsubishi Chemical Group Corp - Notice Regarding Commencement Of Consideration On Spin-Off Of Petrochemicals Business As A Wholly Owned Subsidiary
Bain-backed Tanabe Pharma targets three new drug launches a year in Japan
2025/26 group results (IFRS)